Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marjam-Jeanette Barysch
A New B-Raf Inhibitor Combo for Advanced Melanoma
Oncotarget
Oncology
Related publications
FOXD3 Is a Mutant B-Raf-Regulated Inhibitor of G1-S Progression in Melanoma Cells
Cancer Research
Cancer Research
Oncology
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
Combinatorial Therapies to Overcome B-Raf Inhibitor Resistance in Melanomas
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Targeting Mutant (V600E) B-Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation
Cancer Research
Cancer Research
Oncology
Metabolic Imaging Using Hyperpolarized 13 C‐pyruvate to Assess Sensitivity to the B‐Raf Inhibitor Vemurafenib in Melanoma Cells and Xenografts
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
BCL2/MDM2 Inhibitor Combo Effective in AML
Cancer Discovery
Oncology
Utility of Circulating B-Raf DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy
Clinical Cancer Research
Cancer Research
Oncology
Evaluation of the Immunologic Impact of RAF Inhibitors to Guide Optimal Combination of RAF Inhibitors and Immunotherapy for the Treatment of Advanced Melanoma
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
